Genetic diversity in hereditary axonal neuropathy: Analyzing 53 Brazilian children.
axonal Charcot-Marie-Tooth
hereditary neuropathies
molecular diagnosis
next-generation sequencing
pediatric patients
Journal
Journal of the peripheral nervous system : JPNS
ISSN: 1529-8027
Titre abrégé: J Peripher Nerv Syst
Pays: United States
ID NLM: 9704532
Informations de publication
Date de publication:
20 Feb 2024
20 Feb 2024
Historique:
revised:
24
01
2024
received:
21
01
2023
accepted:
31
01
2024
medline:
20
2
2024
pubmed:
20
2
2024
entrez:
20
2
2024
Statut:
aheadofprint
Résumé
The genetic epidemiology of inherited neuropathies in children remains largely unknown. In this study, we specifically investigated the genetic profile of a Brazilian cohort of pediatric patients with pure or complex axonal neuropathies, a crucial knowledge in the near future for establishing treatment priorities and perspectives for this group of patients. Fifty-three pediatric patients who were assessed prior to reaching the age of 20, and who had clinical diagnoses of axonal hereditary neuropathy or presented with axonal neuropathy as the primary clinical feature, were included in the study. The recruitment of these cases took place from January 1, 2018, to December 31, 2020. The diagnosis was based on clinical and electrophysiological data. A molecular assessment was made using target-gene panel or whole-exome sequencing. Subsequently, segregation analysis was performed on available family members, and all candidate variants found were confirmed through Sanger. A molecular diagnosis was reached in 68% of the patients (n = 36/53), considering only pathogenic and probably pathogenic variants. Variants in MFN2 (n = 15) and GJB1 (n = 3) accounted for half of the genetically confirmed patients (50%; n = 18/36). The other 18 genetically diagnosed patients had variants in several less common genes. Apart from MFN2 and GJB1 genes, universally recognized as a frequent cause of axonal neuropathies in most studied population, our Brazilian cohort of children with axonal neuropathies showed an important genetic heterogeneity, probably reflecting the multi ethnicity of the Brazilian population. Diagnostic, counseling, and future interventions should consider this characteristic.
Sections du résumé
BACKGROUND AND AIMS
OBJECTIVE
The genetic epidemiology of inherited neuropathies in children remains largely unknown. In this study, we specifically investigated the genetic profile of a Brazilian cohort of pediatric patients with pure or complex axonal neuropathies, a crucial knowledge in the near future for establishing treatment priorities and perspectives for this group of patients.
METHODS
METHODS
Fifty-three pediatric patients who were assessed prior to reaching the age of 20, and who had clinical diagnoses of axonal hereditary neuropathy or presented with axonal neuropathy as the primary clinical feature, were included in the study. The recruitment of these cases took place from January 1, 2018, to December 31, 2020. The diagnosis was based on clinical and electrophysiological data. A molecular assessment was made using target-gene panel or whole-exome sequencing. Subsequently, segregation analysis was performed on available family members, and all candidate variants found were confirmed through Sanger.
RESULTS
RESULTS
A molecular diagnosis was reached in 68% of the patients (n = 36/53), considering only pathogenic and probably pathogenic variants. Variants in MFN2 (n = 15) and GJB1 (n = 3) accounted for half of the genetically confirmed patients (50%; n = 18/36). The other 18 genetically diagnosed patients had variants in several less common genes.
INTERPRETATION
CONCLUSIONS
Apart from MFN2 and GJB1 genes, universally recognized as a frequent cause of axonal neuropathies in most studied population, our Brazilian cohort of children with axonal neuropathies showed an important genetic heterogeneity, probably reflecting the multi ethnicity of the Brazilian population. Diagnostic, counseling, and future interventions should consider this characteristic.
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Subventions
Organisme : MRC strategic award to establish an Internatioinal Centre for Genomic Medicine in Neuromuscular Diseases (ICGNMD)
ID : MR/S005021/1
Organisme : Instituto Nacional de Ciência e Tecnologia Translacional em Medicina
Organisme : Programa Nacional de Apoio à Atenção da Saúde da Pessoa com Deficiencia (PRONAS) SIPAR
ID : 25000.160.096/2014-07
Organisme : Conselho Nacional de Pesquisa (CNPq)
ID : 310378/2021-4
Informations de copyright
© 2024 Peripheral Nerve Society.
Références
Barreto LCLS, Oliveira FS, Nunes PS, et al. Epidemiologic study of Charcot-Marie-tooth disease: a systematic review. Neuroepidemiology. 2016;46(3):157-165. doi:10.1159/000443706
Braathen GJ. Genetic epidemiology of Charcot-Marie-tooth disease. Acta Neurol Scand. 2012;126(S193):iv-22. doi:10.1111/ane.12013
Mladenovic J, Milic Rasic V, Keckarevic Markovic M, et al. Epidemiology of Charcot-Marie-tooth disease in the population of Belgrade, Serbia. Neuroepidemiology. 2011;36(3):177-182. doi:10.1159/000327029
Skre H. Genetic and clinical aspects of Charcot-Marie-Tooth's disease. Clin Genet. 1974;6(2):98-118. doi:10.1111/j.1399-0004.1974.tb00638.x
Carroll AS, Burns J, Nicholson G, Kiernan MC, Vucic S. Inherited neuropathies. Semin Neurol. 2019;39(05):620-639. doi:10.1055/s-0039-1693006
Jerath NU, Shy ME. Hereditary motor and sensory neuropathies: understanding molecular pathogenesis could lead to future treatment strategies. Biochim Biophys Acta Mol Basis Dis. 2015;1852(4):667-678. doi:10.1016/j.bbadis.2014.07.031
Pareyson D, Marchesi C. Diagnosis, natural history, and management of Charcot-Marie-tooth disease. Lancet Neurol. 2009;8(7):654-667. doi:10.1016/S1474-4422(09)70110-3
Kleopa KA, Kagiava A, Sargiannidou I. Gene therapy for CMT inherited neuropathy. Muscle Gene Therapy. Springer International Publishing; 2019:621-644. doi:10.1007/978-3-030-03095-7_35
Morelli KH, Hatton CL, Harper SQ, Burgess RW. Gene therapies for axonal neuropathies: available strategies, successes to date, and what to target next. Brain Res. 2020;1732:146683. doi:10.1016/j.brainres.2020.146683
Benarroch L, Bonne G, Rivier F, Hamroun D. The 2020 version of the gene table of neuromuscular disorders (nuclear genome). Neuromuscul Disord. 2019;29(12):980-1018. doi:10.1016/j.nmd.2019.10.010
Juneja M, Burns J, Saporta MA, Timmerman V. Challenges in modelling the Charcot-Marie-tooth neuropathies for therapy development. J Neurol Neurosurg Psychiatry. 2019;90(1):58-67. doi:10.1136/jnnp-2018-318834
Saghira C, Bis DM, Stanek D, et al. Variant pathogenicity evaluation in the community-driven inherited neuropathy variant browser. Hum Mutat. 2018;39(5):635-642. doi:10.1002/humu.23412
Pareyson D, Scaioli V, Laurà M. Clinical and electrophysiological aspects of Charcot-Marie-tooth disease. Neuromolecular Med. 2006;8(1-2):3-22. doi:10.1385/NMM:8:1:123
Harding AE, Thomas PK. The clinical features of hereditary motor and sensory neuropathy types I and II. Brain. 1980;103(2):259-280. doi:10.1093/brain/103.2.259
Saporta ASD, Sottile SL, Miller LJ, Feely SME, Siskind CE, Shy ME. Charcot-marie-tooth disease subtypes and genetic testing strategies. Ann Neurol. 2011;69(1):22-33. doi:10.1002/ana.22166
Tazir M, Hamadouche T, Nouioua S, Mathis S, Vallat JM. Hereditary motor and sensory neuropathies or Charcot-Marie-tooth diseases: an update. J Neurol Sci. 2014;347(1-2):14-22. doi:10.1016/j.jns.2014.10.013
Fridman V, Reilly M. Inherited neuropathies. Semin Neurol. 2015;35(04):407-423. doi:10.1055/s-0035-1558981
Fridman V, Bundy B, Reilly MM, et al. CMT subtypes and disease burden in patients enrolled in the inherited neuropathies consortium natural history study: a cross-sectional analysis. J Neurol Neurosurg Psychiatry. 2015;86(8):873-878. doi:10.1136/jnnp-2014-308826
Murphy SM, Laura M, Fawcett K, et al. Charcot-Marie-tooth disease: frequency of genetic subtypes and guidelines for genetic testing. J Neurol Neurosurg Psychiatry. 2012;83(7):706-710. doi:10.1136/jnnp-2012-302451
Cortese A, Wilcox JE, Polke JM, et al. Targeted next-generation sequencing panels in the diagnosis of Charcot-Marie-tooth disease. Neurology. 2020;94(1):e51-e61. doi:10.1212/WNL.0000000000008672
Wilmshurst JM, Pollard JD, Nicholson G, Antony J, Ouvrier R. Peripheral neuropathies of infancy. Dev Med Child Neurol. 2003;45(6):408-414. doi:10.1017/s0012162203000768
Jani-Acsadi A, Ounpuu S, Pierz K, Acsadi G. Pediatric Charcot-Marie-tooth disease. Pediatr Clin North Am. 2015;62(3):767-786. doi:10.1016/j.pcl.2015.03.012
Kararizou E, Karandreas N, Davaki P, Davou R, Vassilopoulos D. Polyneuropathies in teenagers: a clinicopathological study of 45 cases. Neuromuscul Disord. 2006;16(5):304-307. doi:10.1016/j.nmd.2006.03.001
Shabo G, Pasman JW, van Alfen N, Willemsen MAAP. The spectrum of polyneuropathies in childhood detected with electromyography. Pediatr Neurol. 2007;36(6):393-396. doi:10.1016/j.pediatrneurol.2007.02.013
Borghetti VHS. Análise Fenotipica e Genotipica de Crianças e Adolescentes Portadores de Neuropatia Crônica Com Início Antes Dos 18 Anos. Faculdade de Medicina de Ribeirão Preto. 2010;1(1):1-189.
Tomaselli PJ. Avaliação Das Causas Genéticas Em Pacientes Com Neuropatia Hereditária Utilizando Técnicas de Sequenciamento de Nova Geração (NGS). Faculdade de Medicina de Ribeirão Preto. 2018;1(1):1-193.
Hartley T, Wagner JD, Warman-Chardon J, et al. Whole-exome sequencing is a valuable diagnostic tool for inherited peripheral neuropathies: outcomes from a cohort of 50 families. Clin Genet. 2018;93(2):301-309. doi:10.1111/cge.13101
Drew AP, Zhu D, Kidambi A, et al. Improved inherited peripheral neuropathy genetic diagnosis by whole-exome sequencing. Mol Genet Genom Med. 2015;3(2):143-154. doi:10.1002/mgg3.126
Marques W, Freitas MR, Nascimento OJM, et al. 17p duplicated Charcot-Marie-tooth 1A. J Neurol. 2005;252(8):972-979. doi:10.1007/s00415-005-0797-9
Murphy SM, Herrmann DN, McDermott MP, et al. Reliability of the CMT neuropathy score (second version) in Charcot-Marie-tooth disease. J Peripher Nerv Syst. 2011;16(3):191-198. doi:10.1111/j.1529-8027.2011.00350.x
Richards S, Aziz N, Bale S, et al. Standards and guidelines for the interpretation of sequence variants: a joint consensus recommendation of the American College of Medical Genetics and Genomics and the Association for Molecular Pathology. Genet Med. 2015;17(5):405-423. doi:10.1038/gim.2015.30
Tomaselli PJ, Horga A, Rossor AM, et al. IGHMBP2 mutation associated with organ-specific autonomic dysfunction. Neuromuscul Disord. 2018;28(12):1012-1015. doi:10.1016/j.nmd.2018.08.010
Figueiredo FB, Silva WA, Giuliatti S, et al. GDAP1 mutations are frequent among the autosomal recessive axonal Charcot-Marie-tooth Brazilian patients. Neuromusc Disord. 2021;31:505-511. doi:10.1016/j.nmd.2021.03.005
Sivera R, Sevilla T, Vilchez JJ, et al. Charcot-Marie-tooth disease: genetic and clinical spectrum in a Spanish clinical series. Neurology. 2013;81(18):1617-1625. doi:10.1212/WNL.0b013e3182a9f56a
Nam SH, Bin HY, Hyun YS, et al. Identification of genetic causes of inherited peripheral neuropathies by targeted gene panel sequencing. Mol Cells. 2016;39(5):382-388. doi:10.14348/molcells.2016.2288
Yoshimura A, Yuan JH, Hashiguchi A, et al. Genetic profile and onset features of 1005 patients with Charcot-Marie-tooth disease in Japan. J Neurol Neurosurg Psychiatry. 2019;90(2):195-202. doi:10.1136/jnnp-2018-318839
Padilha JPD, Brasil CS, Hoefel AML, et al. Diagnostic yield of targeted sequential and massive panel approaches for inherited neuropathies. Clin Genet. 2020;98(2):185-190. doi:10.1111/cge.13793
Antoniadi T, Buxton C, Dennis G, et al. Application of targeted multi-gene panel testing for the diagnosis of inherited peripheral neuropathy provides a high diagnostic yield with unexpected phenotype-genotype variability. BMC Med Genet. 2015;16(1):84. doi:10.1186/s12881-015-0224-8
Bacquet J, Stojkovic T, Boyer A, et al. Molecular diagnosis of inherited peripheral neuropathies by targeted next-generation sequencing: molecular spectrum delineation. BMJ Open. 2018;8(10):e021632. doi:10.1136/bmjopen-2018-021632
Hsu Y, Lin K, Guo Y, Tsai Y, Liao Y, Lee Y. Mutation spectrum of Charcot-Marie-tooth disease among the Han Chinese in Taiwan. Ann Clin Transl Neurol. 2019;6(6):1090-1101. doi:10.1002/acn3.50797
Ando M, Okamoto Y, Yoshimura A, et al. Clinical and mutational spectrum of Charcot-Marie-tooth disease type 2Z caused by MORC2 variants in Japan. Eur J Neurol. 2017;24(10):1274-1282. doi:10.1111/ene.13360
Ouvrier RA, Nicholson GA. Advances in the genetics of hereditary hypertrophic neuropathy in childhood. Brain Dev. 1995;17(SUPPL. 1):31-38. doi:10.1016/0387-7604(94)00127-8
Wilmshurst JM, Ouvrier R. Hereditary peripheral neuropathies of childhood: an overview for clinicians. Neuromuscul Disord. 2011;21(11):763-775. doi:10.1016/j.nmd.2011.05.013
Høyer H, Braathen GJ, Eek AK, Nordang GBN, Skjelbred CF, Russell MB. Copy number variations in a population-based study of Charcot-Marie-tooth disease. Biomed Res Int. 2015;2015:1-7. doi:10.1155/2015/960404
Mortreux J, Bacquet J, Boyer A, et al. Identification of novel pathogenic copy number variations in Charcot-Marie-tooth disease. J Hum Genet. 2020;65(3):313-323. doi:10.1038/s10038-019-0710-5
Crimella C, Tonelli A, Airoldi G, et al. The GST domain of GDAP1 is a frequent target of mutations in the dominant form of axonal Charcot Marie tooth type 2K. J Med Genet. 2010;47(10):712-716. doi:10.1136/jmg.2010.077909
Manganelli F, Tozza S, Pisciotta C, et al. Charcot-Marie-tooth disease: frequency of genetic subtypes in a southern Italy population. J Peripher Nerv Syst. 2014;19(4):292-298. doi:10.1111/jns.12092
Marttila M, Kytövuori L, Helisalmi S, et al. Molecular epidemiology of Charcot-Marie-tooth disease in northern Ostrobothnia, Finland: a population-based study. Neuroepidemiology. 2017;49(1-2):34-39. doi:10.1159/000478860
Sevilla T, Lupo V, Martínez-Rubio D, et al. Mutations in the MORC2 gene cause axonal Charcot-Marie-tooth disease. Brain. 2016;139(1):62-72. doi:10.1093/brain/awv311
Choi BO, Koo SK, Park MH, et al. Exome sequencing is an efficient tool for genetic screening of Charcot-Marie-tooth disease. Hum Mutat. 2012;33(11):1610-1615. doi:10.1002/humu.22143
Lupo V, García-García F, Sancho P, et al. Assessment of targeted next-generation sequencing as a tool for the diagnosis of Charcot-Marie-tooth disease and hereditary motor neuropathy. J Mol Diagn. 2016;18(2):225-234. doi:10.1016/j.jmoldx.2015.10.005
Wang W, Wang C, Brian Dawson D, et al. Target-enrichment sequencing and copy number evaluation in inherited polyneuropathy. Neurology. 2016;86(19):1762-1771. doi:10.1212/WNL.0000000000002659
Bertoli-Avella AM, Beetz C, Ameziane N, et al. Successful application of genome sequencing in a diagnostic setting: 1007 index cases from a clinically heterogeneous cohort. Eur J Hum Genet. 2021;29(1):141-153. doi:10.1038/s41431-020-00713-9
Cassini TA, Duncan L, Rives LC, et al. Whole genome sequencing reveals novel IGHMBP2 variant leading to unique cryptic splice-site and Charcot-Marie-tooth phenotype with early onset symptoms. Mol Genet Genom Med. 2019;7(6):676. doi:10.1002/mgg3.676
Tomaselli PJ, Rossor AM, Horga A, et al. Mutations in noncoding regions of GJB1 are a major cause of X-linked CMT. Neurology. 2017;88(15):1445-1453. doi:10.1212/WNL.0000000000003819